Original Articles
Vol. 16 (2021)
https://doi.org/10.3269/1970-5492.2021.16.1
WHAT’S IN CURCUMIN’S MIND? THE POTENTIAL ROLE OF CURCUMINOIDS IN THE TREATMENT OF ALZHEIMER’S DISEASE
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: October 14 2025
Published: October 15 2025
Published: October 15 2025
118
Views
109
Downloads
Neurodegenerative diseases (NDs) are one of major public health problems and their impact is
continuously growing. Curcumin has been proposed for the treatment of several of these
pathologies, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) due to the ability of
this molecule to reduce inflammation and aggregation of involved proteins. Nevertheless, the poor
metabolic stability and bioavailability of curcumin reduce the possibilities of its practical use. In
this review will be highlighted recent results on curcumin and curcuminoids in the search of new
effective therapeutics agents against NDs, with particular emphasis on AD.
Downloads
Download data is not yet available.
How to Cite
WHAT’S IN CURCUMIN’S MIND? THE POTENTIAL ROLE OF CURCUMINOIDS IN THE TREATMENT OF ALZHEIMER’S DISEASE. (2025). EuroMediterranean Biomedical Journal, 16. https://doi.org/10.3269/1970-5492.2021.16.1
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.